Table 6.

Changes in hs‐TNT Level, LE‐Positive Myocardium, Cardiac Morphology, and Function During Follow‐up (n=58) in Patients With and Without ERT

	No ERT	ERT
	n=37	n=21
hs‐TNT*, ng/L
Baseline	4.0 (4.0–10.4)	8.9 (4.8–30.1)†
Follow‐up	6.1 (4.0–18.9)‡	14.6 (6.9–48.0)†, ‡
LE‐positive myocardial volume, %
Baseline	0.2 (0–1.2)	0.6 (0–1.8)
Follow‐up	1.0 (0–2.3)‡	2.3 (0.6–3.9)‡
IVSd, mm
Baseline	10.3±2.2	12.6±3.2†
Follow‐up	10.1±2.2	12.1±2.5†
EF, %
Baseline	65±5	65±5
Follow‐up	64±6	62±7

Using repeated‐measures ANOVA followed by Tukey's post‐hoc test. EF indicates ejection fraction; ERT, enzyme replacement therapy; hs‐TNT, high‐sensitivity cardiac troponin T; IVSd, end‐diastolic interventricular septal wall thickness; LE, late enhancement.

*Ln‐transformed.

^† P<0.05 vs no ERT.

^‡ P<0.05 vs baseline.